Circulating endothelial cells in COVID-19.
作者信息
Nizzoli Maria E, Merati Gabriele, Tenore Annamaria, Picone Cristina, Consensi Erica, Perotti Luciano, Ferretti Virginia V, Sambo Margherita, Di Sabatino Antonio, Iotti Giorgio A, Arcaini Luca, Bruno Raffaele, Belliato Mirko
机构信息
Department of Molecular Medicine, University of Pavia, Pavia, Italy.
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
出版信息
Am J Hematol. 2020 Aug;95(8):E187-E188. doi: 10.1002/ajh.25881. Epub 2020 Jun 20.
Abstract
摘要
相似文献
1
Circulating endothelial cells in COVID-19.
Am J Hematol. 2020 Aug;95(8):E187-E188. doi: 10.1002/ajh.25881. Epub 2020 Jun 20.
2
Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01634-2020. Print 2020 Jul.
3
Endothelial cells orchestrate COVID-19 coagulopathy.
Lancet Haematol. 2020 Aug;7(8):e553-e555. doi: 10.1016/S2352-3026(20)30215-5. Epub 2020 Jun 30.
4
[Recognition of critical coronavirus disease 2019: from the injury of alveolar epithelial cells to vascular endothelial cells].
Zhonghua Nei Ke Za Zhi. 2020 Sep 1;59(9):660-661. doi: 10.3760/cma.j.cn112138-20200323-00283.
5
Management of leprosy patients in the era of COVID-19.
Dermatol Ther. 2020 Jul;33(4):e13631. doi: 10.1111/dth.13631. Epub 2020 Jun 24.
6
Why children avoid the worst coronavirus complications might lie in their arteries.
Nature. 2020 Jun;582(7812):324-325. doi: 10.1038/d41586-020-01692-z.
7
Supplemental oxygen in COVID-19: a friend or foe?
Clin Med (Lond). 2020 Sep;20(5):e137. doi: 10.7861/clinmed.Let.20.5.3.
8
Does active smoking worsen Covid-19?
Eur J Intern Med. 2020 Jul;77:129-131. doi: 10.1016/j.ejim.2020.05.038. Epub 2020 May 28.
9
COVID-19 and Kawasaki disease in children.
Pharmacol Res. 2020 Sep;159:104951. doi: 10.1016/j.phrs.2020.104951. Epub 2020 May 25.
10
Bronchoalveolar lavage findings in severe COVID-19 pneumonia.
Intern Emerg Med. 2020 Oct;15(7):1333-1334. doi: 10.1007/s11739-020-02356-6. Epub 2020 May 15.
引用本文的文献
1
Long COVID's Hidden Complexity: Machine Learning Reveals Why Personalized Care Remains Essential.
J Clin Med. 2025 May 23;14(11):3670. doi: 10.3390/jcm14113670.
2
Coronary Arteries Lesions in Kawasaki Disease: Risk Factors in an Italian Cohort.
Biomedicines. 2024 Sep 3;12(9):2010. doi: 10.3390/biomedicines12092010.
3
Mechanism of COVID-19-Induced Cardiac Damage from Patient, In Vitro and Animal Studies.
Curr Heart Fail Rep. 2023 Oct;20(5):451-460. doi: 10.1007/s11897-023-00618-w. Epub 2023 Aug 1.
4
Toward Blood-Based Precision Medicine: Identifying Age-Sex-Specific Vascular Biomarker Quantities on Circulating Vascular Cells.
Cell Mol Bioeng. 2023 Jul 6;16(3):189-204. doi: 10.1007/s12195-023-00771-1. eCollection 2023 Jun.
5
Circulating Endothelial Cells: A New Possible Marker of Endothelial Damage in Kawasaki Disease, Multisystem Inflammatory Syndrome in Children and Acute SARS-CoV-2 Infection.
Int J Mol Sci. 2022 Sep 3;23(17):10106. doi: 10.3390/ijms231710106.
6
The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo.
Mol Med. 2022 Apr 9;28(1):40. doi: 10.1186/s10020-022-00465-w.
7
Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
Mol Cancer. 2022 Mar 25;21(1):86. doi: 10.1186/s12943-022-01556-2.
8
Cytokine Storms in the Course of COVID-19 and Haemophagocytic Lymphohistiocytosis in Pregnant and Postpartum Women.
Biomolecules. 2021 Aug 13;11(8):1202. doi: 10.3390/biom11081202.
9
The Prothrombotic State Associated with SARS-CoV-2 Infection: Pathophysiological Aspects.
Mediterr J Hematol Infect Dis. 2021 Jul 1;13(1):e2021045. doi: 10.4084/MJHID.2021.045. eCollection 2021.
10
Immunothrombotic dysregulation in chagas disease and COVID-19: a comparative study of anticoagulation.
Mol Cell Biochem. 2021 Oct;476(10):3815-3825. doi: 10.1007/s11010-021-04204-3. Epub 2021 Jun 10.
本文引用的文献
1
Electron microscopy of SARS-CoV-2: a challenging task.
Lancet. 2020 May 30;395(10238):e99. doi: 10.1016/S0140-6736(20)31188-0. Epub 2020 May 19.
2
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19.
N Engl J Med. 2020 Jul 9;383(2):120-128. doi: 10.1056/NEJMoa2015432. Epub 2020 May 21.
3
Endothelial cell infection and endotheliitis in COVID-19.
Lancet. 2020 May 2;395(10234):1417-1418. doi: 10.1016/S0140-6736(20)30937-5. Epub 2020 Apr 21.
4
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.
5
Circulating endothelial cells as biomarker for cardiovascular diseases.
Res Pract Thromb Haemost. 2018 Oct 26;3(1):49-58. doi: 10.1002/rth2.12158. eCollection 2019 Jan.
6
A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges.
Sci Rep. 2018 Apr 11;8(1):5823. doi: 10.1038/s41598-018-24234-0.
7
Evaluation of endothelial damage in sepsis-related ARDS using circulating endothelial cells.
Intensive Care Med. 2015 Feb;41(2):231-8. doi: 10.1007/s00134-014-3589-9. Epub 2014 Dec 16.
8
Measurement of circulating endothelial cells to support the diagnosis of veno-occlusive disease after hematopoietic stem cell transplantation.
Int J Lab Hematol. 2014 Aug;36(4):e27-9. doi: 10.1111/ijlh.12137. Epub 2013 Aug 28.
Zotero 插件